Chemokines in colon cancer progression
SN Jia, YB Han, R Yang, ZC Yang - Seminars in cancer biology, 2022 - Elsevier
Colon cancer is a major human cancer accounting for about a tenth of all cancer cases thus
making it among the top three cancers in terms of incidence as well as mortality. Metastasis …
making it among the top three cancers in terms of incidence as well as mortality. Metastasis …
Sphingosine 1-phosphate modulation and immune cell trafficking in inflammatory bowel disease
Immune cell trafficking is a critical element of the intestinal immune response, both in
homeostasis and in pathological conditions associated with inflammatory bowel disease …
homeostasis and in pathological conditions associated with inflammatory bowel disease …
Colonic microbiota is associated with inflammation and host epigenomic alterations in inflammatory bowel disease
FJ Ryan, AM Ahern, RS Fitzgerald… - Nature …, 2020 - nature.com
Studies of inflammatory bowel disease (IBD) have been inconclusive in relating microbiota
with distribution of inflammation. We report microbiota, host transcriptomics, epigenomics …
with distribution of inflammation. We report microbiota, host transcriptomics, epigenomics …
The interleukin-23/interleukin-17 axis links adaptive and innate immunity in psoriasis
MP Schön, L Erpenbeck - Frontiers in immunology, 2018 - frontiersin.org
Research into the pathophysiology of psoriasis has shed light onto many fascinating
immunological interactions and underlying genetic constellations. Most prominent among …
immunological interactions and underlying genetic constellations. Most prominent among …
Chemokines and chemokine receptors as therapeutic targets in inflammatory bowel disease; pitfalls and promise
PJ Trivedi, DH Adams - Journal of Crohn's and Colitis, 2018 - academic.oup.com
The principal targets for anti-chemokine therapy in inflammatory bowel disease (IBD) have
been the receptors CCR9 and CXCR3 and their respective ligands CCL25 and CXCL10 …
been the receptors CCR9 and CXCR3 and their respective ligands CCL25 and CXCL10 …
Role of chemokine systems in cancer and inflammatory diseases
H Li, M Wu, X Zhao - MedComm, 2022 - Wiley Online Library
Chemokines are a large family of small secreted proteins that have fundamental roles in
organ development, normal physiology, and immune responses upon binding to their …
organ development, normal physiology, and immune responses upon binding to their …
DUOX2 variants associate with preclinical disturbances in microbiota-immune homeostasis and increased inflammatory bowel disease risk
H Grasberger, AT Magis, E Sheng… - The Journal of …, 2021 - Am Soc Clin Investig
A primordial gut-epithelial innate defense response is the release of hydrogen peroxide by
dual NADPH oxidase (DUOX). In inflammatory bowel disease (IBD), a condition …
dual NADPH oxidase (DUOX). In inflammatory bowel disease (IBD), a condition …
Probiotic Lactobacillus and Bifidobacterium Strains Counteract Adherent-Invasive Escherichia coli (AIEC) Virulence and Hamper IL-23/Th17 Axis in Ulcerative Colitis …
Hypersecretion of proinflammatory cytokines and dysregulated activation of the IL-23/Th17
axis in response to intestinal microbiota dysbiosis are key factors in the pathogenesis of …
axis in response to intestinal microbiota dysbiosis are key factors in the pathogenesis of …
CCR6 as a potential target for therapeutic antibodies for the treatment of inflammatory diseases
S Gómez-Melero, J Caballero-Villarraso - Antibodies, 2023 - mdpi.com
The CC chemokine receptor 6 (CCR6) is a G protein-coupled receptor (GPCR) involved in a
wide range of biological processes. When CCR6 binds to its sole ligand CCL20, a signaling …
wide range of biological processes. When CCR6 binds to its sole ligand CCL20, a signaling …
Discovery of small-molecules targeting the CCL20/CCR6 axis as first-in-class inhibitors for inflammatory bowel diseases
MG Martina, C Giorgio, M Allodi, S Palese… - European Journal of …, 2022 - Elsevier
The CCL20/CCR6 axis is implicated in the migration of CCR6+ immune cells towards
CCL20, its sole ligand, whose expression is increased during inflammatory processes and is …
CCL20, its sole ligand, whose expression is increased during inflammatory processes and is …